US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816

PURPOSE: Four US National Clinical Trials Network components (Southwest Oncology Group, Cancer and Leukemia Group B/Alliance, Eastern Cooperative Oncology Group, and the AIDS Malignancy Consortium) conducted a phase II Intergroup clinical trial that used early interim fluorodeoxyglucose positron emi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Oncol
Glavni autori: Press, Oliver W., Li, Hongli, Schöder, Heiko, Straus, David J., Moskowitz, Craig H., LeBlanc, Michael, Rimsza, Lisa M., Bartlett, Nancy L., Evens, Andrew M., Mittra, Erik S., LaCasce, Ann S., Sweetenham, John W., Barr, Paul M., Fanale, Michelle A., Knopp, Michael V., Noy, Ariela, Hsi, Eric D., Cook, James R., Lechowicz, Mary Jo, Gascoyne, Randy D., Leonard, John P., Kahl, Brad S., Cheson, Bruce D., Fisher, Richard I., Friedberg, Jonathan W.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2016
Teme:
ORIGINAL REPORTS
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966513/
https://ncbi.nlm.nih.gov/pubmed/27069074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.63.1119
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items